Video profile
Locations
U of M Pediatrics Hematology/Oncology
U of M Pediatric Hematology Oncology
Credentials
Medical School or Training
-
N.H.L Municipal Medical College, 1988
Residency
-
K.M. School Post Graduate Study and Research, Pediatrics, 1992
-
SUNY Health Science Center, Pediatrics, NY, 1997
Fellowship
-
Pediatric Oncology, Gujarat Cancer & Research Institute MP Shah Cancer Hospital, 1994
-
Pediatric Hematology/Oncology, University of Michigan Medical Center, 2000
Professional Organizations
-
APHO
-
Children's Oncology Group
-
American Society of Hematology Board Certification
-
Pediatric Hematology-Oncology
Board Certification
-
Pediatric Hematology-Oncology
Research
New Drug Development against childhood cancers Principal Investigator: A COG Phase-II, randomized trial of IMC-A12 or CEP-701 in combination with Irinotecan/ Temozolomide. Principal Investigator: An institutional Phase-I trial of Bortezomib in combination with Irinotecan in refractory / relapsed neuroblastoma Principle Investigator: Children's Oncology Group, Phase-I/ Pilot Consortium studies at C.S. Mott Children's Hospital, University of Michigan (Aug 2006-Current). Health Outcomes in Childhood Cancer Survivors Role Of FDG-PET in Pediatric Malignancies
Biography
Dr. Rajen Mody joined the Division of Pediatric Hematology/Oncology following completion of his fellowship training in pediatric hematology/oncology at the University of Michigan. Before coming to Michigan, Dr. Mody completed a pediatric residency at the State University of New York, in New York City. His research interests include the role of MXI, a putative tumor suppressor gene, in neuro-blastoma pathogenesis.